Practical Considerations for ctDNA Testing

This segment addresses practical considerations in ctDNA testing, including optimal timing, frequency, and communication with patients. Panelists describe using relatively frequent testing intervals, often every six weeks in the perioperative setting, to capture dynamic changes in molecular disease burden. They emphasize that trends over time are more informative than single measurements, particularly when evaluating treatment response or recurrence risk. The discussion also highlights the challenges of explaining ctDNA results to patients, as positive or negative findings may not always translate into clear treatment decisions. Clinicians stress the importance of shared decision-making, tailoring discussions based on patient preferences, anxiety levels, and clinical context. This segment underscores the need to balance the clinical value of sensitive molecular data with thoughtful, patient-centered communication in everyday practice.